ACET

Adicet Bio, Inc.CIK 1720580 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ACET PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ACET

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Klickstein Lloyd	Director	11	$0	$0	2026-08-05
Peng Katie	Director	10	$0	$0	2026-06-21
Sinclair Andrew	Director	34	$14.00M	$0	2026-06-21
Grissinger Michael	Director	2	$0	$0	2026-06-21
Chodakewitz Jeffrey	Director	26	$0	$0	2026-06-21
DUBIN STEVE	Director	27	$12.0K	$0	2026-06-21
Aftab Blake	Chief Scientific Officer	41	$0	$564.0K	2026-06-19
Schor Chen	President and CEO	87	$15.1K	$5.15M	2026-06-19
Shah Rajeev M.	10% Owner	2	$0	$0	2026-04-27
OrbiMed Advisors Israel II Ltd	Director, 10% Owner	7	$7.50M	$674.8K	2026-04-08
Maltzman Julia D.	Chief Medical Officer	2	$0	$0	2026-03-25
Healey Don	Chief Technology Officer	34	$0	$117.8K	2026-03-25
Harvey Brian Nicholas	Chief Financial Officer	31	$0	$0	2026-03-25
RA Capital Healthcare Fund LP	10% Owner	3	$1.60M	$0	2026-02-20
ORBIMED ADVISORS LLC	Director, 10% Owner	6	$6.83M	$0	2025-10-08
Jakobovits Aya	Director	45	$0	$799.5K	2024-08-21
Kauffman Michael	Director	19	$0	$8.4K	2024-08-21
GORDON CARL L	Director, 10% Owner	36	$9.33M	$0	2024-08-21
Galimi Francesco	See Remarks	46	$0	$327.6K	2024-06-05
Sanna Bastiano	Director	16	$0	$0	2023-08-14
OrbiMed Israel GP II, L.P.	Director, 10% Owner	1	$0	$0	2021-12-10
ABBOT STEWART	See Remarks	6	$0	$0	2021-06-11
Krehlik Carrie	Chief Human Resources Officer	5	$0	$0	2021-02-12
Chimovits Erez	Director, 10% Owner	5	$0	$0	2021-02-12
OrbiMed Israel GP Ltd.	Director, 10% Owner	2	$0	$0	2021-02-12
Schindel Yair Chaim	Director	2	$0	$0	2020-09-17
OrbiMed Capital GP VI LLC	Director, 10% Owner	5	$0	$0	2020-09-17
DEBENEDITTIS FRANK	Sr. Vice President	62	$0	$2.13M	2019-02-26
Scally Frances P	SVP, CHIEF ACCOUNTING OFFICER	4	$0	$8.0K	2018-12-26
Alaimo Charles John	Vice President	41	$0	$819.6K	2018-10-04
Rogers Steven	Sr. V.P. & General Counsel	31	$0	$704.1K	2018-10-04
EILENDER ALBERT L	Chairman & Chief Exec. Officer	49	$0	$2.31M	2018-10-04
Kaczmarek Walter J III	Chief Operating Officer	7	$0	$188.8K	2018-09-07
BORKOWSKI EDWARD	CHIEF FINANCIAL OFFICER	1	$0	$0	2018-02-21
Yarosh Daniel B.	Director	5	$0	$18.4K	2017-12-07
Giordano Natasha	Director	12	$0	$157.2K	2017-12-07
BRITTON WILLIAM N	Director	17	$0	$466.4K	2017-12-07
LEVIN ALAN G	Director	5	$18.4K	$0	2017-12-07
Kennally William C. III	PRESIDENT AND CEO	2	$0	$0	2017-10-02
ROTH DOUGLAS A	Sr. Vice President & CFO	63	$0	$2.84M	2017-09-07
GUCCIONE SALVATORE J SR	President & COO	31	$40.6K	$1.28M	2017-09-07
Kippley Terry	Sr. Vice President	27	$0	$577.3K	2016-12-09
Bartone Raymond	Sr. Vice President	26	$0	$824.4K	2016-12-09
Shackley Nicolas I	Sr. Vice Prsident - API	17	$0	$419.1K	2016-12-08
NOETZLI HANS C	Director	26	$0	$485.4K	2016-12-01
Srinivasan Satish	President & COO - Rising Pharm	13	$0	$678.0K	2016-11-29
Restrepo Carlos	Sr. Vice President	5	$0	$10.1K	2016-09-01
Weaving Roger Jr	Sr. Vice President	21	$0	$578.7K	2014-02-14
Randall Richard P	Director	2	$0	$0	2013-12-05
WIESEN ROBERT A	Director	8	$0	$105.8K	2013-08-08
Hippel Lukas von	Managing Director	3	$0	$0	2013-07-25
Saint-Clair Guillaume	V.P. Pharma Intermediates	22	$0	$224.6K	2013-07-25
Van Eis Jan	VP-API EMERGING MARKETS	10	$0	$135.9K	2013-07-25
Gold Ronald	President & COO - Rising Pharm	5	$0	$1.30M	2013-05-24
Rosen David B.	Sr. V.P. - Rising Pharma	5	$41.9K	$493.9K	2013-05-14
Bender Ulf	Managing Director	3	$0	$4.8K	2011-12-12

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Klickstein Lloyd	Chief Medical Officer	A Award deriv	2026-08-05	2026-08-07	18,300	—	$0	18,300	SEC↗
Klickstein Lloyd	Chief Medical Officer, Direc	A Award deriv	2026-08-05	2026-08-07	18,300	—	$0	18,300	SEC↗
Klickstein Lloyd	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
Peng Katie	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
Sinclair Andrew	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
Grissinger Michael	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
DUBIN STEVE	Director	A Award deriv	2026-06-21	2026-06-23	4,200	—	$0	4,200	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2026-06-19	2026-06-23	55,000	—	$0	55,000	SEC↗
Schor Chen	President & CEO	A Award deriv	2026-06-19	2026-06-23	55,000	—	$0	55,000	SEC↗
Shah Rajeev M.	10% Owner	J Other deriv	2026-04-27	2026-04-29	250,000	—	$0	1,402,833	SEC↗
Shah Rajeev M.	10% Owner	J Other	2026-04-27	2026-04-29	250,000	—	$0	932,624	SEC↗
OrbiMed Advisors Israel II Ltd	10% Owner	S Sale	2026-04-08	2026-04-09	40,416	$6.52	$263.5K	0	SEC↗
OrbiMed Advisors Israel II Ltd	10% Owner	S Sale	2026-04-08	2026-04-09	32,523	$6.29	$204.6K	0	SEC↗
OrbiMed Advisors Israel II Ltd	10% Owner	S Sale	2026-04-07	2026-04-09	2,400	$6.38	$15.3K	32,523	SEC↗
OrbiMed Advisors Israel II Ltd	10% Owner	S Sale	2026-04-07	2026-04-09	29,319	$6.53	$191.5K	34,923	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2026-03-25	2026-03-27	72,555	—	$0	72,555	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2026-03-25	2026-03-27	43,361	—	$0	43,361	SEC↗
Maltzman Julia D.	Chief Medical Officer	A Award deriv	2026-03-25	2026-03-27	72,555	—	$0	72,555	SEC↗
Schor Chen	President & CEO	A Award deriv	2026-03-25	2026-03-27	468,555	—	$0	468,555	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2026-03-25	2026-03-27	43,361	—	$0	43,361	SEC↗
RA Capital Healthcare Fund LP	10% Owner	P Buy	2026-02-20	2026-04-13	74,751	$7.27	$543.4K	1,182,624	SEC↗
RA Capital Healthcare Fund LP	10% Owner	P Buy	2026-02-19	2026-04-13	74,268	$7.21	$535.5K	1,107,873	SEC↗
RA Capital Healthcare Fund LP	10% Owner	P Buy	2026-02-18	2026-04-13	74,577	$7.04	$525.0K	1,033,605	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	F Tax w/h	2026-01-24	2026-01-27	546	$8.44	$4.6K	5,145	SEC↗
Schor Chen	President & CEO	F Tax w/h	2026-01-24	2026-01-27	1,755	$8.44	$14.8K	6,820	SEC↗
Healey Don	Chief Technology Officer	F Tax w/h	2026-01-24	2026-01-27	535	$8.44	$4.5K	3,452	SEC↗
Aftab Blake	Chief Scientific Officer	F Tax w/h	2026-01-24	2026-01-27	535	$8.44	$4.5K	2,981	SEC↗
ORBIMED ADVISORS LLC	10% Owner	P Buy	2025-10-08	2025-10-10	3,500,000	$1.00	$3.50M	4,490,254	SEC↗
ORBIMED ADVISORS LLC	10% Owner	P Buy	2025-10-08	2025-10-10	1,500,000	$1.00	$1.50M	9,026,359	SEC↗
Sinclair Andrew	Director	A Award deriv	2025-06-11	2025-06-13	26,400	—	$0	26,400	SEC↗
Peng Katie	Director	A Award deriv	2025-06-11	2025-06-13	26,400	—	$0	26,400	SEC↗
DUBIN STEVE	Director	A Award deriv	2025-06-11	2025-06-13	26,400	—	$0	26,400	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2025-06-11	2025-06-13	26,400	—	$0	26,400	SEC↗
Klickstein Lloyd	Director	A Award deriv	2025-06-11	2025-06-13	26,400	—	$0	26,400	SEC↗
Sinclair Andrew	Director	A Award	2025-06-11	2025-06-13	5,900	—	$0	17,700	SEC↗
Peng Katie	Director	A Award	2025-06-11	2025-06-13	5,900	—	$0	11,800	SEC↗
DUBIN STEVE	Director	A Award	2025-06-11	2025-06-13	5,900	—	$0	22,700	SEC↗
Chodakewitz Jeffrey	Director	A Award	2025-06-11	2025-06-13	5,900	—	$0	17,700	SEC↗
Klickstein Lloyd	Director	A Award	2025-06-11	2025-06-13	5,900	—	$0	108,566	SEC↗
Grissinger Michael	Director	A Award deriv	2025-04-17	2025-04-21	70,200	—	$0	70,200	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2025-01-31	2025-02-04	324,040	—	$0	324,040	SEC↗
Maltzman Julia D.	Chief Medical Officer	A Award deriv	2025-01-31	2025-02-04	750,000	—	$0	750,000	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2025-01-31	2025-02-04	275,000	—	$0	275,000	SEC↗
Schor Chen	President & CEO	A Award deriv	2025-01-31	2025-02-04	763,829	—	$0	763,829	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2025-01-31	2025-02-04	275,000	—	$0	275,000	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	F Tax w/h	2025-01-24	2025-01-28	8,752	$0.92	$8.1K	91,048	SEC↗
Aftab Blake	Chief Scientific Officer	F Tax w/h	2025-01-24	2025-01-28	6,270	$0.92	$5.8K	56,241	SEC↗
Healey Don	Chief Technology Officer	F Tax w/h	2025-01-24	2025-01-28	8,560	$0.92	$7.9K	63,769	SEC↗
Schor Chen	President & CEO	F Tax w/h	2025-01-24	2025-01-28	28,101	$0.92	$25.9K	137,201	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2024-08-21	2024-08-23	30,000	—	$0	30,000	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2024-08-21	2024-08-23	30,000	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
Kauffman Michael	Director	D To issuer deriv	2024-08-21	2024-08-23	37,000	—	$0	0	SEC↗
Kauffman Michael	Director	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Kauffman Michael	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Kauffman Michael	Director	A Award deriv	2024-08-21	2024-08-23	37,000	—	$0	37,000	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2024-08-21	2024-08-23	30,000	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2024-08-21	2024-08-23	30,000	—	$0	30,000	SEC↗
DUBIN STEVE	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2024-08-21	2024-08-23	30,000	—	$0	30,000	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2024-08-21	2024-08-23	30,000	—	$0	0	SEC↗
Peng Katie	Director	A Award deriv	2024-08-21	2024-08-23	70,200	—	$0	70,200	SEC↗
Peng Katie	Director	D To issuer deriv	2024-08-21	2024-08-23	70,200	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2024-08-21	2024-08-23	30,000	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-08-21	2024-08-23	30,000	—	$0	30,000	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2024-08-21	2024-08-23	8,172	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-08-21	2024-08-23	8,172	—	$0	8,172	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2024-08-21	2024-08-23	18,500	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-08-21	2024-08-23	18,500	—	$0	18,500	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2024-08-21	2024-08-23	26,400	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-08-21	2024-08-23	26,400	—	$0	26,400	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-08-21	2024-08-23	28,828	—	$0	28,828	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2024-08-21	2024-08-23	28,828	—	$0	0	SEC↗
Klickstein Lloyd	Director	A Award deriv	2024-08-19	2024-08-20	70,200	—	$0	70,200	SEC↗
Sinclair Andrew	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
Peng Katie	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
DUBIN STEVE	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
Jakobovits Aya	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-06-05	2024-06-07	26,400	—	$0	26,400	SEC↗
Schor Chen	President & CEO	A Award deriv	2024-06-05	2024-06-07	1,770,427	—	$0	1,770,427	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2024-06-05	2024-06-07	271,595	—	$0	271,595	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2024-06-05	2024-06-07	374,829	—	$0	374,829	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2024-06-05	2024-06-07	375,077	—	$0	375,077	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2024-06-05	2024-06-07	336,911	—	$0	336,911	SEC↗
Sinclair Andrew	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	11,800	SEC↗
Peng Katie	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	5,900	SEC↗
Kauffman Michael	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	11,800	SEC↗
Kauffman Michael	Director	S Sale	2024-06-05	2024-06-07	5,900	$1.43	$8.4K	5,900	SEC↗
DUBIN STEVE	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	16,800	SEC↗
Jakobovits Aya	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	11,800	SEC↗
Chodakewitz Jeffrey	Director	A Award	2024-06-05	2024-06-07	5,900	—	$0	11,800	SEC↗
GORDON CARL L	Director, 10% Owner	A Award	2024-06-05	2024-06-07	5,900	—	$0	11,800	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	1,841,100	$2.40	$4.42M	7,526,359	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	1,041,700	$2.40	$2.50M	1,255,985	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	242,200	$2.40	$581.3K	990,254	SEC↗
OrbiMed Advisors Israel II Ltd	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	1,841,100	$2.40	$4.42M	7,526,359	SEC↗
OrbiMed Advisors Israel II Ltd	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	1,041,700	$2.40	$2.50M	1,255,985	SEC↗
OrbiMed Advisors Israel II Ltd	Director, 10% Owner	P Buy	2024-01-25	2024-01-26	242,200	$2.40	$581.3K	990,254	SEC↗
Schor Chen	President & CEO	A Award deriv	2024-01-24	2024-01-26	1,116,903	—	$0	1,116,903	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2024-01-24	2024-01-26	288,022	—	$0	288,022	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2024-01-24	2024-01-26	211,633	—	$0	211,633	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2024-01-24	2024-01-26	241,173	—	$0	241,173	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2024-01-24	2024-01-26	288,134	—	$0	288,134	SEC↗
Schor Chen	President & CEO	F Tax w/h	2024-01-24	2024-01-26	15,290	$2.40	$36.7K	138,471	SEC↗
Schor Chen	President & CEO	A Award	2024-01-24	2024-01-26	70,300	—	$0	208,771	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	F Tax w/h	2024-01-24	2024-01-26	4,320	$2.40	$10.4K	73,500	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award	2024-01-24	2024-01-26	26,300	—	$0	99,800	SEC↗
Healey Don	Chief Technology Officer	F Tax w/h	2024-01-24	2024-01-26	4,870	$2.40	$11.7K	52,629	SEC↗
Healey Don	Chief Technology Officer	A Award	2024-01-24	2024-01-26	19,700	—	$0	72,329	SEC↗
Aftab Blake	Chief Scientific Officer	F Tax w/h	2024-01-24	2024-01-26	3,565	$2.40	$8.6K	42,811	SEC↗
Aftab Blake	Chief Scientific Officer	A Award	2024-01-24	2024-01-26	19,700	—	$0	62,511	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	F Tax w/h	2024-01-24	2024-01-26	4,957	$2.40	$11.9K	75,501	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award	2024-01-24	2024-01-26	26,300	—	$0	101,801	SEC↗
Aftab Blake	Chief Scientific Officer	F Tax w/h	2023-10-12	2023-10-16	7,933	$1.35	$10.7K	46,376	SEC↗
Schor Chen	President & CEO	P Buy	2023-10-02	2023-10-02	5,500	$1.33	$7.3K	43,469	SEC↗
Schor Chen	President & CEO	F Tax w/h	2023-10-02	2023-10-02	23,208	$1.37	$31.8K	153,761	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	F Tax w/h	2023-10-02	2023-10-03	7,096	$1.37	$9.7K	77,820	SEC↗
Healey Don	Chief Technology Officer	F Tax w/h	2023-10-02	2023-10-03	9,069	$1.37	$12.4K	57,499	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	F Tax w/h	2023-10-02	2023-10-03	8,093	$1.37	$11.1K	80,458	SEC↗
Schor Chen	President & CEO	S Sale	2023-09-29	2023-10-02	5,500	$1.36	$7.5K	176,969	SEC↗
Schor Chen	President & CEO	P Buy	2023-09-28	2023-10-02	5,500	$1.42	$7.8K	182,469	SEC↗
Schor Chen	President & CEO	S Sale	2023-09-28	2023-10-02	5,500	$1.42	$7.8K	37,969	SEC↗
Peng Katie	Director	D To issuer deriv	2023-08-14	2023-08-16	70,200	—	$0	0	SEC↗
Peng Katie	Director	A Award deriv	2023-08-14	2023-08-16	70,200	—	$0	70,200	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2023-08-14	2023-08-16	30,000	—	$0	30,000	SEC↗
Chodakewitz Jeffrey	Director	D To issuer deriv	2023-08-14	2023-08-16	30,000	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Jakobovits Aya	Director	A Award deriv	2023-08-14	2023-08-16	30,000	—	$0	30,000	SEC↗
Jakobovits Aya	Director	D To issuer deriv	2023-08-14	2023-08-16	30,000	—	$0	0	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2023-08-14	2023-08-16	30,000	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2023-08-14	2023-08-16	30,000	—	$0	30,000	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
DUBIN STEVE	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
DUBIN STEVE	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
DUBIN STEVE	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	D To issuer deriv	2023-08-14	2023-08-16	37,000	—	$0	0	SEC↗
Kauffman Michael	Director	A Award deriv	2023-08-14	2023-08-16	37,000	—	$0	37,000	SEC↗
Kauffman Michael	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Kauffman Michael	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Kauffman Michael	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2023-08-14	2023-08-16	8,172	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-08-14	2023-08-16	8,172	—	$0	8,172	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-08-14	2023-08-16	28,828	—	$0	28,828	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2023-08-14	2023-08-16	28,828	—	$0	0	SEC↗
Sanna Bastiano	Director	D To issuer deriv	2023-08-14	2023-08-16	28,828	—	$0	0	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-08-14	2023-08-16	28,828	—	$0	28,828	SEC↗
Sanna Bastiano	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Sanna Bastiano	Director	D To issuer deriv	2023-08-14	2023-08-16	1,172	—	$0	0	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-08-14	2023-08-16	1,172	—	$0	1,172	SEC↗
Sanna Bastiano	Director	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
Sanna Bastiano	Director	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-08-14	2023-08-16	30,000	—	$0	30,000	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2023-08-14	2023-08-16	18,500	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-08-14	2023-08-16	18,500	—	$0	18,500	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2023-08-14	2023-08-16	26,400	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-08-14	2023-08-16	26,400	—	$0	26,400	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2023-08-14	2023-08-16	30,000	—	$0	0	SEC↗
Healey Don	Chief Technology Officer	D To issuer deriv	2023-08-14	2023-08-16	117,200	—	$0	0	SEC↗
Healey Don	Chief Technology Officer	D To issuer deriv	2023-08-14	2023-08-16	70,000	—	$0	0	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-08-14	2023-08-16	149,944	—	$0	149,944	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-08-14	2023-08-16	117,200	—	$0	117,200	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-08-14	2023-08-16	70,000	—	$0	70,000	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-08-14	2023-08-16	125,000	—	$0	125,000	SEC↗
Healey Don	Chief Technology Officer	D To issuer deriv	2023-08-14	2023-08-16	125,000	—	$0	0	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-08-14	2023-08-16	30,400	—	$0	30,400	SEC↗
Healey Don	Chief Technology Officer	D To issuer deriv	2023-08-14	2023-08-16	30,400	—	$0	0	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	D To issuer deriv	2023-08-14	2023-08-16	28,200	—	$0	0	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-08-14	2023-08-16	125,000	—	$0	125,000	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	D To issuer deriv	2023-08-14	2023-08-16	125,000	—	$0	0	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-08-14	2023-08-16	28,200	—	$0	28,200	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	D To issuer deriv	2023-08-14	2023-08-16	117,200	—	$0	0	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-08-14	2023-08-16	90,000	—	$0	90,000	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	D To issuer deriv	2023-08-14	2023-08-16	90,000	—	$0	0	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-08-14	2023-08-16	176,308	—	$0	176,308	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-08-14	2023-08-16	117,200	—	$0	117,200	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-08-14	2023-08-16	56,612	—	$0	56,612	SEC↗
Aftab Blake	Chief Scientific Officer	D To issuer deriv	2023-08-14	2023-08-16	56,612	—	$0	0	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-08-14	2023-08-16	50,000	—	$0	50,000	SEC↗
Aftab Blake	Chief Scientific Officer	D To issuer deriv	2023-08-14	2023-08-16	50,000	—	$0	0	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-08-14	2023-08-16	117,200	—	$0	117,200	SEC↗
Aftab Blake	Chief Scientific Officer	D To issuer deriv	2023-08-14	2023-08-16	117,200	—	$0	0	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-08-14	2023-08-16	60,000	—	$0	60,000	SEC↗
Aftab Blake	Chief Scientific Officer	D To issuer deriv	2023-08-14	2023-08-16	60,000	—	$0	0	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-08-14	2023-08-16	125,000	—	$0	125,000	SEC↗
Aftab Blake	Chief Scientific Officer	D To issuer deriv	2023-08-14	2023-08-16	125,000	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	113,652	—	$0	113,652	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	113,652	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	117,200	—	$0	117,200	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	77,269	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	77,269	—	$0	77,269	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	73,964	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	73,964	—	$0	73,964	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	26,625	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	26,625	—	$0	26,625	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	125,000	—	$0	0	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-08-14	2023-08-16	125,000	—	$0	125,000	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	D To issuer deriv	2023-08-14	2023-08-16	117,200	—	$0	0	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	36,857	—	$0	36,857	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	872,111	—	$0	0	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	295,000	—	$0	0	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	36,857	—	$0	0	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	384,900	—	$0	384,900	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	384,900	—	$0	0	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	421,600	—	$0	421,600	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	421,600	—	$0	0	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	240,000	—	$0	240,000	SEC↗
Schor Chen	President & CEO	D To issuer deriv	2023-08-14	2023-08-16	240,000	—	$0	0	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	872,111	—	$0	872,111	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-08-14	2023-08-16	295,000	—	$0	295,000	SEC↗
Peng Katie	Director	A Award deriv	2023-07-10	2023-07-11	70,200	—	$0	70,200	SEC↗
DUBIN STEVE	Director	P Buy	2023-06-30	2023-06-30	5,000	$2.40	$12.0K	10,900	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	125,000	$2.09	$261.2K	1,027,885	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	250,000	$2.09	$522.5K	646,657	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	442,000	$2.09	$923.8K	5,685,259	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	58,000	$2.09	$121.2K	748,054	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	125,000	$2.09	$261.2K	1,027,885	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	250,000	$2.09	$522.5K	646,657	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	442,000	$2.09	$923.8K	5,685,259	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-06-27	2023-06-29	58,000	$2.09	$121.2K	748,054	SEC↗
Sinclair Andrew	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
DUBIN STEVE	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
GORDON CARL L	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
Jakobovits Aya	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
Kauffman Michael	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
Sanna Bastiano	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
Chodakewitz Jeffrey	Director	A Award deriv	2023-06-01	2023-06-02	26,400	—	$0	26,400	SEC↗
Sinclair Andrew	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
DUBIN STEVE	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
GORDON CARL L	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
Jakobovits Aya	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
Kauffman Michael	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
Sanna Bastiano	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
Chodakewitz Jeffrey	Director	A Award	2023-06-01	2023-06-02	5,900	—	$0	5,900	SEC↗
Healey Don	Chief Technology Officer	S Sale	2023-02-15	2023-02-17	4,533	$7.57	$34.3K	66,568	SEC↗
Healey Don	Chief Technology Officer	S Sale	2023-02-10	2023-02-14	10,467	$7.98	$83.5K	71,101	SEC↗
Schor Chen	President & CEO	A Award deriv	2023-01-24	2023-01-26	384,900	—	$0	384,900	SEC↗
Aftab Blake	Chief Scientific Officer	A Award deriv	2023-01-24	2023-01-26	117,200	—	$0	117,200	SEC↗
Healey Don	Chief Technology Officer	A Award deriv	2023-01-24	2023-01-26	117,200	—	$0	117,200	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award deriv	2023-01-24	2023-01-26	117,200	—	$0	117,200	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award deriv	2023-01-24	2023-01-26	117,200	—	$0	117,200	SEC↗
Schor Chen	President & CEO	A Award	2023-01-24	2023-01-26	85,500	—	$0	176,969	SEC↗
Aftab Blake	Chief Scientific Officer	A Award	2023-01-24	2023-01-26	26,100	—	$0	54,309	SEC↗
Healey Don	Chief Technology Officer	A Award	2023-01-24	2023-01-26	26,100	—	$0	81,568	SEC↗
Harvey Brian Nicholas	Chief Financial Officer	A Award	2023-01-24	2023-01-26	26,100	—	$0	84,916	SEC↗
Galimi Francesco	SVP & Chief Medical Officer	A Award	2023-01-24	2023-01-26	26,100	—	$0	88,551	SEC↗
Schor Chen	President & CEO	S Sale	2022-11-10	2022-11-15	9,955	$21.03	$209.4K	91,469	SEC↗